Unknown

Dataset Information

0

Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping.


ABSTRACT:

Background

The binding of the T cell receptor (TCR) to major histocompatibility complex (MHC) molecules in the thymus determines fates of TCRalphabeta lymphocytes that subsequently home to secondary lymphoid tissue. TCR transgenic models have been used to study thymic selection and lineage commitment. Most TCR transgenic mice express the rearranged TCRalphabeta prematurely at the double negative stage and abnormal TCRalphabeta populations of T cells that are not easily detected in non-transgenic mice have been found in secondary lymphoid tissue of TCR transgenic mice.

Methodology and principal findings

To determine developmental pathways of TCR-transgenic thymocytes, we used Cre-LoxP-mediated fate mapping and show here that premature expression of a transgenic TCRalphabeta diverts some developing thymocytes to a developmental pathway which resembles that of gamma delta cells. We found that most peripheral T cells with the HY-TCR in male mice have bypassed the RORgammat-positive CD4(+)8(+) (double positive, DP) stage to accumulate either as CD4(-)8(-) (double negative, DN) or as CD8alpha(+) T cells in lymph nodes or gut epithelium. Likewise, DN TCRalphabeta cells in lymphoid tissue of female mice were not derived from DP thymocytes.

Conclusion

The results further support the hypothesis that the premature expression of the TCRalphabeta can divert DN thymocytes into gamma delta lineage cells.

SUBMITTER: Egawa T 

PROVIDER: S-EPMC2211402 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2118105 | BioStudies
2007-01-01 | S-EPMC1829260 | BioStudies
1000-01-01 | S-EPMC5587556 | BioStudies
2019-01-01 | S-EPMC6372634 | BioStudies
2013-01-01 | S-EPMC3759406 | BioStudies
1000-01-01 | S-EPMC5392268 | BioStudies
1000-01-01 | S-EPMC3145744 | BioStudies
2015-01-01 | S-EPMC4433242 | BioStudies
2004-01-01 | S-EPMC524847 | BioStudies
1000-01-01 | S-EPMC2200817 | BioStudies